B. Braun designs, manufactures and supplies medical technologies and integrated healthcare solutions globally. Founded in 1839 with the purchase of the Rose Pharmacy in Melsungen, Germany, the company has evolved through six generations of family stewardship into one of the world's leading medical technology providers, with annual sales of approximately €9.4 billion and more than 64,000 employees worldwide.
The company operates across multiple segments within healthcare. Its infusion equipment division pioneered single-use plastic infusion devices in the 1950s, including the Braunüle product, which advanced patient safety and comfort. B. Braun's portfolio extends to dialysis and extracorporeal blood treatment technologies, clinical nutrition products such as Lipofundin (introduced in 1962), and surgical instruments through its Aesculap division. The company maintains operations spanning every continent.
B. Braun's technical capabilities span medical device design and manufacturing, pharmaceutical production, clinical nutrition, renal care systems, and surgical technology. The company's longstanding focus centres on developing integrated healthcare solutions that combine medical devices, pharmaceuticals and clinical expertise to address patient needs across multiple treatment areas.
